Medtronic Company Intelligence Report - Biologics Market Research

Medtronic Company Intelligence Report
Published Date: September 2006
Published By: Espicom Healthcare Intelligence
Page Count: 196
Order Code: R16-78
Price: $795 Online Download
$795Hard Copy Mail Delivery
Medtronic is one of the world?s leading medical technology companies, specialising in implantable and interventional therapies. This report provides a full review of the company's activities.
Medtronic, headquartered in Minneapolis, Minnesota, USA, is a medical technology company specialised in implantable and interventional therapies. Over the last five years, Medtronic?s revenue has more than doubled, rising from US$5 billion in fiscal 2000 to over US$11 billion in fiscal 2006,.
Medtronic?s products are organised within seven operating segments:
Cardiac Rhythm Disease Management - Medtronic?s largest operating division, accounting for 46% of the company?s total revenue in fiscal 2006. Products include cardiac resynchronisation therapy (CRT) devices, pacemakers, implantable and external defibrillators, leads and ablation products.
Vascular - Includes drug-eluting and other coronary stents, balloon and guiding catheters, endovascular stent grafts, embolic protection products and peripheral vascular products. In fiscal 2006, sales from this division accounted for 8% of Medtronic?s total revenue.
Cardiac Surgery - Includes perfusion systems, heart valves, minimally-invasive cardiac surgery products and accessories. In fiscal 2006, sales from the segment accounted for 6% of Medtronic?s revenue.
Spinal and Navigation - Includes thoracolumbar, cervical and interbody spinal devices and surgical navigation tools. Revenue from the segment accounted for 20% of Medtronic?s sales in fiscal 2006.
Neurological - Includes implantable neurostimulation devices, implantable drug administration systems and Medtronic?s obesity management products. The division generated 9% of Medtronic?s revenue in fiscal 2006.
Diabetes - Includes systems for the treatment of diabetes. The division generated 6% of Medtronic?s revenue in fiscal 2006.
ENT - Includes surgical products used by ENT physicians and neurology products. Revenue from the segment accounted for 4% of Medtronic?s sales in fiscal 2006.
Medtronic?s largest geographic market is the US, which accounted for 67.5% of the company?s total revenue in fiscal 2006, while sales from Europe accounted for 20.5% of total revenue, sales from the Asia-Pacific region for 9.1% and other international markets for 2.9%. During the year, Medtronic?s revenue from customers in the US increased by 13.6% to US$7.6 billion, while European sales rose by 10.3% to US$2.3 billion, sales from the Asia-Pacific region grew by 3.8% to US$1 billion and sales from other countries increased by 26.9% to US$329.3 million.
This company report provides:
Executive Summary
An overview of the company, including operating activities, at a glance key events and strategic focus.
Product Portfolio and R&D
The product section of the report focuses on the key aspects of the company's portfolio and technology, covering core products, key brands, new products and analysis of the competition. Sales data, market size and future potential is included where available.
International Activities
The company's business activities by geographic region and country.
Appendices
Financial Indicators
Key corporate events
Mergers & acquisitions
Joint Ventures
Minority investments
Divestitures
Agreements
Litigation